Literature DB >> 3359847

Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study.

J M Wallace1, J B Hannah.   

Abstract

Despite the recognition of Mycobacterium avium complex (MAC) infection as a common complication of AIDS, the specific clinical features, significance, and need for treatment have been difficult to assess. We reviewed the clinical records and autopsy material of 68 patients dying with AIDS, 32 (47 percent) of whom had MAC isolated from autopsy tissue. All had postmortem evidence of systemic infection. Eleven (34 percent) had MAC isolated from lung tissue. Little, if any, local tissue inflammation and destruction were associated with MAC infection. Patients with autopsy evidence of MAC infection had a longer time interval from diagnosis of AIDS to death. The infection was detected antemortem in 14 (44 percent), blood culture being the most sensitive means (86 percent yield). Although recurrent fever was noted among both MAC infected and uninfected patients, weight loss greater than 20 lb, weakness, anorexia, abdominal pain, and diarrhea were more frequent among infected patients. Severe anemia, thrombocytopenia, lymphopenia, and reduced mean CD-4 percentages and CD-4/CD-8 ratios were associated with MAC infection. Of eight patients who had MAC cultured antemortem and received multidrug antituberculosis therapy, none responded clinically, and all but one had MAC isolated at autopsy. Because MAC is associated with significant discomfort and disability, development of more effective treatment regimens could be beneficial for some affected AIDS patients.

Entities:  

Mesh:

Year:  1988        PMID: 3359847     DOI: 10.1378/chest.93.5.926

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  27 in total

Review 1.  Treatment of pulmonary disease caused by opportunist mycobacteria.

Authors:  J Banks
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

Review 2.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

3.  Choroidal lesions in patients with AIDS.

Authors:  M A Rosenblatt; C Cunningham; S Teich; A H Friedman
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

4.  Stimulation with cytokines enhances penetration of azithromycin into human macrophages.

Authors:  L E Bermudez; C Inderlied; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

5.  Detection and identification of Mycobacterium avium in the blood of AIDS patients by the polymerase chain reaction.

Authors:  M A De Francesco; D Colombrita; G Pinsi; F Gargiulo; S Caligaris; D Bertelli; F Martinelli; J Gao; A Turano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

6.  Serovars of Mycobacterium avium complex isolated from patients in Denmark.

Authors:  D S Askgaard; S B Giese; S Thybo; A Lerche; J Bennedsen
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

7.  Mycobacterium simiae disseminated infection in a patient with acquired immunodeficiency syndrome.

Authors:  B Vandercam; J Gala; B Vandeweghe; J Degraux; G Wauters; L Larsson; A Bourlond; F Portaels
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

8.  Clinical diagnosis of mycobacterial diseases versus autopsy findings in 350 patients with AIDS.

Authors:  A d'Arminio Monforte; L Vago; A Gori; S Antinori; F Franzetti; C M Antonacci; E Sala; L Catozzi; L Testa; R Esposito; M Nebuloni; M Moroni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

Review 9.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  Identification of a beta 1 integrin on Mycobacterium avium-Mycobacterium intracellulare.

Authors:  S P Rao; K R Gehlsen; A Catanzaro
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.